-+ 0.00%
-+ 0.00%
-+ 0.00%

US FDA: APPROVES TALAZOPARIB WITH ENZALUTAMIDE FOR METASTATIC HRR-MUTATED PROSTATE CANCER

Reuters·10/26/2026 16:43:54

Please log in to view news